TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from CVS Group plc ( (GB:CVSG) ) is now available.
CVS Group plc announced the purchase of 24,380 of its ordinary shares as part of a share buyback program initiated in October 2025. The shares were bought at prices ranging from 1,216.00 to 1,230.00 GBp and will be canceled, reducing the total number of shares in issue to 71,038,131. This move is part of a broader strategy to manage the company’s capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:CVSG) stock is a Hold with a £1420.00 price target. To see the full list of analyst forecasts on CVS Group plc stock, see the GB:CVSG Stock Forecast page.
Spark’s Take on GB:CVSG Stock
According to Spark, TipRanks’ AI Analyst, GB:CVSG is a Neutral.
CVS Group plc’s overall stock score reflects a mixed outlook. Financial performance is strong in revenue growth but challenged by profitability issues. Technical indicators show short-term bearish trends, and valuation suggests overvaluation. However, positive corporate events and strategic moves support long-term growth prospects.
To see Spark’s full report on GB:CVSG stock, click here.
More about CVS Group plc
CVS Group plc is an AIM-listed provider of veterinary services operating in the UK and Australia. The company focuses on delivering high-quality clinical services through its approximately 470 veterinary practices, which include specialist referral hospitals and out-of-hours sites. CVS also runs diagnostic laboratories and an online retail business, Animed Direct, employing around 8,900 personnel, including 2,400 veterinary surgeons and 3,300 nurses.
Average Trading Volume: 433,072
Technical Sentiment Signal: Buy
Current Market Cap: £869.8M
Learn more about CVSG stock on TipRanks’ Stock Analysis page.